Alpha Laboratories has been acquired by Diploma, a FTSE 100 UK-listed group specialising in value-added technical products and services across life sciences, seals, and controls. Diploma will add value by providing essential products and solutions through a decentralised, customer-orientated approach within each of its end markets.
Rob Vint, Managing Director of Alpha Laboratories, said: “Our extensive range of value-added diagnostic solutions make us an excellent fit with Diploma, whose focus is the creation, innovation, and delivery of value-added solutions within its life sciences division. We also share an ethos. Our passion for sustainability, proven ESG credentials, outstanding ISO accreditation, and significant academic accreditation amongst our employees is something that is mirrored across the group.”
As one of the fastest growing diagnostics companies in the UK and Ireland, with leading market positions in bowel cancer and inflammatory bowel disease screening, Alpha’s regional footprint and product expertise are a natural fit within the Diploma Life Sciences sector.
The company says its commitment to customers, passion for products, and deep clinical expertise is paramount to Alpha’s continued success. A partnership with Diploma will allow Alpha to remain agile and responsive while giving it the added strength of a public company that maintains the highest standards of compliance, commercial practice, and customer-centric vision.
Alpha Laboratories will continue to operate under the same brand, from the same location, representing the same products and suppliers, with the same employees and leadership that customers have come to know and trust.
For more information, please visit: www.alphalabs.co.uk/diploma